Boothbay Fund Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-44,909
| Closed | -$74.1K | – | 1426 |
|
|
2024
Q3 | $74.1K | Hold |
44,909
| – | – | ﹤0.01% | 1286 |
|
|
2024
Q2 | $99.7K | Sell |
44,909
-2,462
| -5% | -$5.47K | ﹤0.01% | 1191 |
|
|
2024
Q1 | $127K | Sell |
47,371
-49,362
| -51% | -$132K | ﹤0.01% | 1219 |
|
|
2023
Q4 | $289K | Sell |
96,733
-269,565
| -74% | -$806K | 0.01% | 1044 |
|
|
2023
Q3 | $359K | Buy |
366,298
+32,031
| +10% | +$31.4K | 0.01% | 1006 |
|
|
2023
Q2 | $465K | Buy |
334,267
+70,175
| +27% | +$97.5K | 0.01% | 944 |
|
|
2023
Q1 | $420K | Buy |
264,092
+30,657
| +13% | +$48.7K | 0.01% | 1118 |
|
|
2022
Q4 | $1.45M | Sell |
233,435
-29,623
| -11% | -$185K | 0.03% | 605 |
|
|
2022
Q3 | $1.76M | Sell |
263,058
-8,485
| -3% | -$56.8K | 0.04% | 543 |
|
|
2022
Q2 | $1.73M | Buy |
+271,543
| New | +$1.73M | 0.05% | 535 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 677 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 691 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 636 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 701 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 660 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 627 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 658 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 566 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 634 |
|